GLPG-0492
- Generic Name
- GLPG-0492
- Drug Type
- Small Molecule
- Chemical Formula
- C19H14F3N3O3
- CAS Number
- 1215085-92-9
- Unique Ingredient Identifier
- 8O59X1ACZT
- Background
Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
GLPG0492 Pharmacodynamics
- First Posted Date
- 2012-02-24
- Last Posted Date
- 2012-04-19
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 26
- Registration Number
- NCT01538420
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects
- First Posted Date
- 2011-07-19
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 24
- Registration Number
- NCT01397370
- Locations
- 🇩🇪
Parexel Early Phase Clinical Unit, Berlin, Germany
First-in-Human Single Ascending Dose of GLPG0492
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 28
- Registration Number
- NCT01130818
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath